ACAD Competitors & Alternatives
Compare ACADIA Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ACAD
Main Stock$25.72
Tradestie Score
57
Market Cap
$3.58B
P/E Ratio
11.4
Revenue Growth
0.1%
Analyst Upside
+25.6%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.01
|
$4.94B | - | 59 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$86.73
|
$4.93B | - | 55 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$86.71
|
$4.84B | - | 64 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$129.57
|
$3.98B | - | 60 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$43.88
|
$3.92B | - | 64 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$115.67
|
$3.91B | - | 57 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.95
|
$3.83B | - | 56 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.99
|
$3.68B | - | 56 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$121.61
|
$3.67B | - | 55 | Compare |
More ACAD Analysis
Data updated: Jul 06, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry